Megaron Athens Concert Hall,
Athens, 21-23/10/2022
IASIS PHARMA participated in the 42nd Panhellenic Congress of Cardiology of HSC, actively expressing its interest in the specialty of cardiology, for which the company offers original & generic medicines.
The Conference took place on October 21-23, 2022, at the Megaron Athens Concert Hall and is considered as the largest medical conference in the country, with the participation of approximately 2,000 Health Care Professionals. The Conference had a broad and multifaceted scientific agenda and was held in five conference rooms.
IASIS PHARMA participated with an exhibition stand, that the experts had the opportunity to visit and get informed about the company’s wide range, high-quality medicines:
– Rami-Amlo®, a fixed-dose combination of Ramipril & Amlodipine in a single dosage form, in packages of 28 capsules, available in 4 strengths:
5mg / 5mg,
5mg / 10mg,
10mg / 5mg,
10mg / 10mg.
Rami-Amlo Plus®, also an original fixed-dose combination of Ramipril – Amlodipine –Hydrochlorothiazide, which is available in packages of 30 capsules, in a wide range of strengths:
(Ramipril / Amlodipine / Hydrochlorothiazide)
5 mg / 5 mg / 12,5 mg
5 mg / 5 mg / 25 mg,
10 mg / 5 mg / 25 mg,
10 mg / 10 mg / 25 mg.
Licepler®: Licepler® (eplerenone) available in packages of 30 film-coated tablets, in 25mg and 50mg strengths.
MAG-IASIS® the first uniquely effective combination of 1193.57 mg magnesium citrate & 667.56 mg magnesium aspartate, equivalent to 243 mg Magnesium, indicated for magnesium deficiency, in the form of 40 effervescent tablets.
